Capital Allergy and Respiratory Disease Center — Sacramento, California

Capital Allergy and Respiratory Disease Center is a clinical research site located in Sacramento, California, United States.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Capital Allergy and Respiratory Disease Center has participated in 2 clinical trials.

Therapeutic areas: Cystic Fibrosis, Perennial Allergic Rhinitis.

Sponsors: Gilead Sciences, Meda Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capital Allergy and Respiratory Disease Center?

Capital Allergy and Respiratory Disease Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capital Allergy and Respiratory Disease Center conducted?

Capital Allergy and Respiratory Disease Center has 2 clinical trials on record. Their work covers Cystic Fibrosis, Perennial Allergic Rhinitis.

Is Capital Allergy and Respiratory Disease Center accredited by Crixeo Health?

Capital Allergy and Respiratory Disease Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Capital Allergy and Respiratory Disease Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.